The Board remands the claim for an initial compensable rating for dyshidrosis to secure outstanding treatment records and obtain a new opinion addressing the nature of medications used to treat the condition.
The deciding factor: The addendum opinion was inadequate as it neglected to address the use of Clobetasol, as noted by the Court and in previous examination reports.
- Claimed conditions
- dyshidrosis
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 11, 2022
- Citation
- 22001385
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.